Craig K. Svensson
1984 Ph.D.; State University of New York at Buffalo
1984-85 Postdoctoral Fellowship; State University of New York at Buffalo
Dr. Svensson's biomedical research interests have primarily focused on understanding the mechanism of idiosyncratic drug reactions, with a particular emphasis on cutaneous drug reactions. He is no longer directing a laboratory research program.
Dr. Svensson's current scholarship is focused on addiction and living with chronic illness or pain.
Service and Engagement
Associate Editor, AAPS Journal
Member, Board of Governors, Riley Children's Foundation
Ad hoc grant reviewer, National Science Foundation
Reviewer for Biochemical Pharmacology, Clinical Pharmacology & Therapeutcs, Drug Metabolism and Disposition, JAMA, JAMA Open Network, JAPhA, Journal of Pharmacology & Experimental Therapeutics, Pharmacological Reviews, Toxicology Letters
HONR 39900 - Drug Addiction: What Is It and What Should We Do About It? (sole intructor)
PHRM 46000 - Drug Discovery and Development (lecturer)
PHRM 82400 - Principles Of Pathophysiology And Drug Action (lecturer)
PHRM84500 - Integrated Pharmacotherapy (co-coordinator, lecturer)
PHRM 84700 - Pharmacogenomics (lecturer)
NUR 50200 - Pharmacotherapeutics in Advanced Nursing Practice (lecturer)
IUSoM - Fundamentals of Health and Disease (lecturer)
IUSoM - Neuroscience and Behavior (lecturer)
Honors and Credentials
175th Anniversary Distinguished Alumni, University of Maryland School of Pharmacy
Fellow, American Association of Pharmaceutical Scientists
Fellow, American Association for the Advancement of Science
“Balancing the Pharmaceutical Sciences and Practice in a Pharmacy Curriculum.” FIP Pharmaceutical Sciences World Congress. October 5, 2020.
Svensson CK: We won’t force addicts to change. Quillette August 23, 2022.
Svensson CK. Opioid-induced hyperalgesia: Is it a clinically relevant phenomenon? International Journal of Pharmacy Practice 30:479-483, 2022.
Svensson CK. Breaking the Grip of Addiction: How is Drug Addiction Started, Sustained, and Stopped? Consilium Publishing, 2022.
Svensson CK. Attenuation of response to repeated drug administration: A proposal for differentiating tachyphylaxis and tolerance. Journal of Pharmacology and Experimental Therapeutics 381:22-32, 2022.
Svensson CK: Drug Distribution and Protein Binding, In: Shargel L, Ducharme M, Yu ABC (eds) Applied Biopharmaceutics and Pharmacokinetics, 8th edition, McGraw Hill, New York, 2022.
Svensson CK. CBD for the treatment of pain - What is the evidence? Journal of the American Pharmacists Association 60:e80-e83, 2020.
Svensson CK. When There Is No Cure: How to Thrive While Living with the Pain and Suffering of Chronic Illness, Consilium Publishing, 2019.
Svensson CK. What should constitute an acceptable advanced pharmacy practice experience? American Journal of Pharmaceutical Education, 80: Article 37, 2016.
Svensson CK. Should a pharmacy dean be a pharmacist? American Journal of Pharmaceutical Education 79: Article 32, 2015.
Krasniak AE, Knipp GT, Svensson CK, Liu W. Pharmacogenomics of acetaminophen in pediatric populations: a moving target. Frontiers in Genetics 5: Article 314, 2014.
Guglielmo JB, Svensson CK. Tobacco sales in pharmacies: What will it take to quit for good? Drug Topics p. 2, March 2014.
Kehrer JP, Svensson CK. Advancing scholarship and research within academic pharmacy. American Journal of Pharmaceutical Education 76:Article 187, 2012.
Bauman JL, Ascione FJ, Brueggemeier RW, Letendre DE, Roberts JC, Speedie MK, Svensson CK. On research, the change in the academy and accreditation. American Journal of Pharmaceutical Education 76:Article 144, 2012.
Svensson CK, Ascione FJ, Bauman JL, Brueggemeier RW, Letendre DE, Roberts JC, Speedie MK. Are we producing innovators and leaders or change resisters and followers? American Journal of Pharmaceutical Education 76:Article 124, 2012.
Galinsky RE, Svensson CK. Basic Pharmacokinetics and Pharmacodynamics, In: Gennaro AR (ed), Remington's Pharmaceutical Sciences, 22nd edition, pp. 1073-1093, 2012.
Svensson CK, Speedie MK, Roberts JC, Letendre DE, Brueggemeier RW, Bauman JL, Ascione FJ. Reconsidering the length of program accreditation. American Journal of Pharmaceutical Education 75:Article 6, 2011.
Svensson CK. Biotransformation of drugs in human skin. Drug Metabolism and Disposition 37:247-253, 2009.
Svensson CK: Drug Eruptions, In: Gaspari AA, Tyring SK (eds), Clinical Immunodermatology, Springer Verlag, London, pp. 263-276, 2008.